| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.13B | — | +7.4% |
| Gross Profit | $1.98B | — | -1.7% |
| R&D Expense | $345.0M | — | +0.3% |
| SG&A Expense | $1.12B | — | +7.4% |
| Operating Income | $515.0M | — | -18.1% |
| Interest Expense | $96.0M | — | -12.7% |
| Pre-tax Income | $505.0M | — | -27.0% |
| Income Tax | $94.0M | — | -9.6% |
| Net Income | $389.0M | — | -31.0% |
| EPS (Basic) | $0.85 | — | -30.9% |
| EPS (Diluted) | $0.85 | — | -30.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.26B | -49.7% | -7.9% |
| Accounts Receivable | $3.79B | -4.3% | +6.0% |
| Inventory | $2.35B | +5.3% | +9.0% |
| Current Assets | $10.43B | -16.6% | +7.1% |
| Total Assets | $37.13B | +0.6% | +10.5% |
| Current Liabilities | $8.53B | -6.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $290.0M | — | +16.0% |
| Investing Cash Flow | -$2.50B | — | -514.3% |
| Financing Cash Flow | $21.0M | — | +107.3% |
| -14.4% |
| Long-term Debt | $10.13B | +1.3% | +15.7% |
| Total Liabilities | $26.23B | -0.3% | +8.5% |
| Stockholders' Equity | $10.67B | +2.8% | +16.1% |